RecruitingNCT06782984

Drug Response Testing and Repurposing Using Glioblastoma Organoid

Studying Germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chungnam National University Hospital
Principal Investigator
Kyung Hwan Kim, MD, PhD
Department of Neurosurgery, Chungnam National University Hospital
Intervention
Organoid-based drug sensitivity test(other)
Enrollment
150 target
Eligibility
All sexes
Timeline
2021 – 2030

Study locations (1)

Collaborators

Korea Advanced Institute of Science and Technology · Keimyung University Dongsan Medical Center · Soonchunhyang University Hospital · Dong-A University Hospital · Yeungnam University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06782984 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor →

← Back to all trials